section name header

Use and Dosing ⬇

Adult Dosing

As an adjunct to Percutaneous Coronary Intervention (PCI)

Reconstitution

Transitioning patients to oral P2Y12 therapy

Note:

Pediatric Dosing

Indications ⬆ ⬇

Contraindications ⬆ ⬇

Black Box Warnings ⬆ ⬇

Dosing Adjustment ⬆ ⬇

Renal Dose Adjustment

Hepatic Dose Adjustment

Warnings/Precautions ⬆ ⬇

Pregnancy/Breast Feeding ⬆ ⬇

Pregnancy Category:C

Breastfeeding: Safety unknown

Adverse Reactions ⬆ ⬇

Clinical Pharmacology ⬆ ⬇

Brands and Availability ⬆ ⬇

flag_usa32.png

US Trade Name(s)

US Availability

Kengreal

flag_canada32.png

Canadian Trade Name(s)

Canadian Availability

flag_uk32.png

UK Trade Name(s)

UK Availability

Kengrexal

flag_australia32.png

Australian Trade Name(s)

Australian Availability

Classification ⬆

Cardiovascular

Antiplatelet Agents

Hematology/Oncology

Antiplatelet Agents